Command Palette

Search for a command to run...

Clinical Trials · NCT04883346

Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy

CompletedPhase 2Liraglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Enrollment
34
Start date
Jun 2021
Locations
1 site, United States
Primary endpoint
Cohen's d (the Standardized Mean Difference)
View Liraglutide compound reference